US Stock MarketDetailed Quotes

Pacira BioSciences (PCRX)

Watchlist
  • 22.590
  • -0.870-3.71%
Close Feb 26 16:00 ET
  • 21.300
  • -1.290-5.71%
Post 18:23 ET
928.45MMarket Cap48.06P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Pacira BioSciences (PCRX) Revenue Breakdown Overview

By Business/Source

Currency:USD
2025/Q3
Stock NameRevenueRatio
EXPAREL139.9M77.93%
ZILRETTA28.98M16.14%
iovera°6.47M3.60%
Bupivacaine liposome injectable suspension2.69M1.50%
Royalty revenue1.48M0.82%

By Country/Region

Currency:USD
2024/FY
Stock NameRevenueRatio
US, European Union (E.U.) and United Kingdom (UK)548.96M78.32%
United States118.09M16.85%
U.S., Canada and Europe22.81M3.25%
Bupivacaine liposome injectable suspension7.32M1.04%
Royalty revenue3.78M0.54%
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +5.74%
Sample Name
Sample Code
 +4.99%
Sample Name
Sample Code
 +4.90%
4
Roblox
RBLX
+4.89%
5
Salesforce
CRM
+4.03%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +5.69%
Sample Name
Sample Code
 +5.01%
Sample Name
Sample Code
 +4.84%
4
Taiwan Semiconductor
TSM
+4.56%
5
ASE Technology
ASX
+4.53%
View More
Trump cheers on towards 100,000! Will the Dow continue its surge after breaking through 50,000 point
On February 10 Eastern Time, the Dow Jones Industrial Average hit another all-time high! Previously, on February 6, the Dow surpassed the hi Show More
Is the US stock market entering a recovery phase? Trump and Jensen Huang both 'chiming in' with these three key trends worth watching!
Wait for the right moment to act

- No more -